Biomedcl Res Fdn Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BIOMEDCL RES FDN
BIOMEDCL RES FDN has four approved drugs.
Summary for Biomedcl Res Fdn
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 4 |
Drugs and US Patents for Biomedcl Res Fdn
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biomedcl Res Fdn | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 203837-001 | May 1, 2015 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Biomedcl Res Fdn | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 203710-001 | May 1, 2015 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Biomedcl Res Fdn | SODIUM FLUORIDE F-18 | sodium fluoride f-18 | INJECTABLE;INTRAVENOUS | 204351-001 | Jan 9, 2015 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Biomedcl Res Fdn | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 204352-001 | May 1, 2015 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
